Prelude Therapeutics (PRLD)
NASDAQ:PRLD
Want to see PRLD full AI Analyst Report?
Prelude Therapeutics (PRLD) Ownership Overview
36.92% Insiders
2.37% Mutual Funds
37.60% Other Institutional Investors
1.92% ETFs
21.19% Public Companies and
Individual Investors
The ownership structure of Prelude Therapeutics (PRLD) stock is a mix of institutional, retail, and individual investors. Approximately 41.89% of the company’s stock is owned by Institutional Investors, 36.92% is owned by Insiders, and 21.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 23, 2026 | xxxxxxxxxxxxx | $12499999 | |
Apr 23, 2026 | xxxxxxxxxxxxx | $12499999 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $38793 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,123,824 | Institution | 15.59% | 45,152,255 | |
| 9,252,951 | Insider | 14.25% | 41,268,161 | |
| 6,475,882 | Insider | 9.98% | 28,882,434 | |
| 3,669,054 | Insider | 5.65% | 16,363,981 | |
| 1,652,426 | Insider | 2.55% | 7,369,820 | |
| 1,652,426 | Insider | 2.55% | 7,369,820 | |
| 1,212,967 | Institution | 1.87% | 5,409,833 | |
| 1,199,157 | Institution | 1.85% | 5,348,240 | |
| 500,098 | Insider | 0.77% | 2,230,437 | |
| 480,123 | Insider | 0.74% | 2,141,349 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,199,157 | Institution | 1.85% | 5,348,240 | |
| 230,675 | Institution | 0.36% | 1,028,811 | |
| 50,000 | Institution | 0.08% | 223,000 | |
| 18,431 | Institution | 0.03% | 82,202 | |
| 13,804 | Institution | 0.02% | 61,566 | |
| 12,818 | Institution | 0.02% | 57,168 | |
| 6,792 | Institution | 0.01% | 30,292 | |
| 4,982 | Institution | <0.01% | 22,220 | |
| 2,571 | Institution | <0.01% | 11,467 | |
| 1,227 | Institution | <0.01% | 5,472 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 936,001 | Institution | 1.44% | 3,669,124 | |
| 275,975 | Institution | 0.43% | 1,081,822 | |
| 15,986 | Institution | 0.02% | 38,207 | |
| 13,637 | Institution | 0.02% | 60,821 | |
| 8,690 | Institution | 0.01% | 29,720 | |
| 7,414 | Institution | 0.01% | 33,289 | |
| 3,323 | Institution | <0.01% | 13,658 | |
| 1,348 | Institution | <0.01% | 5,540 |
FAQ
Who Owns Prelude Therapeutics (PRLD)?
According to the latest TipRanks data, approximately 37.60% of the company's stock is held by institutional investors, 36.92% is held by insiders, and 21.19% is held by retail investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.60% of Prelude Therapeutics (PRLD) stock is held by institutional investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.19% of Prelude Therapeutics (PRLD) stock is held by retail investors.
Who owns the most shares of Prelude Therapeutics (PRLD)?
Felix Baker owns the most shares of Prelude Therapeutics (PRLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.